Doximity, Inc. Class A Common Stock (DOCS)
R&D Expenses
$38.48M
Quarterly · Period ending: · USD
DOCS R&D Expenses
Latest reported$38.48Mperiod ending
Latest reported$38.48Mperiod ending
DOCS Quarterly R&D Expenses ($8.61M → $38.48M)
Quarterly R&D Expenses
High-resolution chart · PNG
DOCS r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 38,477,000 | |
| 39,106,000 | |
| 34,595,000 | |
| 30,202,000 | |
| 26,799,000 | |
| 24,803,000 | |
| 22,421,000 | |
| 23,240,000 | |
| 22,574,000 | |
| 20,148,000 | |
| 19,946,000 | |
| 19,958,000 | |
| 21,931,000 | |
| 21,541,000 | |
| 20,519,000 | |
| 19,104,000 | |
| 19,022,000 | |
| 17,424,000 | |
| 16,225,000 | |
| 15,460,000 | |
| 13,241,000 | |
| 12,558,000 | |
| 11,406,000 | |
| 9,866,000 | |
| 10,043,000 | |
| 8,891,000 | |
| 8,605,000 |